Reply to: Mifamurtide in Nonmetastatic High-Grade Osteosarcoma

Emanuela Palmerini1, Massimo Serra1, Toni Ibrahim1

  • 1Emanuela Palmerini, MD, PhD, Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, Massimo Serra, PhD and Toni Ibrahim, MD, PhD, Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Javier Martín Broto, MD, PhD, Research Health Institute of Fundacion Jimenez Diaz (IIS/FJD; UAM), Madrid, Spain, Department of Medical Oncology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain, University Hospital General de Villalba, Madrid, Spain.

Summary

No abstract available in PubMed .